Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 481 (CSE: $PRMO.C) (TSXV: $ENW.V) (CSE: $IPOT.C) (TSX: $FAF.TO) (OTCQX: $FFLWF)
Today's podcast sponsored by Cannabis Suisse Corp. (OTC: $CSUI), a fully licensed cannabis cultivation and distribution company in Switzerland
Delta, Kelowna, BC, October 14, 2020 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast edition of cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
Today’s podcast overview/transcript:
Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.
Today’s podcast is sponsored by Cannabis Suisse Corp. (OTC: CSUI ), a fully licensed cannabis cultivation and distribution company in Switzerland, for recreational tobacco products and medical CBD oils. The Company's facilities for producing cannabis are based in Dietikon, Switzerland, and contain the art surveillance equipment to enable an around the clock webcast. Cannabis Suisse grows high quality, organic cannabis with sustainable, all-natural principles. The Company's products are laboratory tested to ensure the end users have access to a standardized, safe and consistent product. Cannabis Suisse proprietary trademarked MoldStandard is a quantitative microbiology method for analyzing yeast and mold counts in harvested cannabis plants. Cannabis Suisse proprietary trademarked CannaMec is a method for quantifying and removing residual solvents during packaging and storage of CBD products. Cannabis Suisse Corp. currently sells via a distribution network of Swiss retailers and online shops, under the retail brand Alpine Cannabis.
In today’s podcast we look at a few public company announcements.
PRIMO NUTRACEUTICALS INC. (CSE: PRMO) (OTC: BUGVF) announced entering into a non-binding letter of intent with MedCanBiotechnologies Inc. who will act as a consultant to conduct a chemo typing (Chemical Analysis) and a genotyping (Genetic Analysis) study of up to 5 strains of Psilocybin mushrooms (commonly known as Magic Mushrooms).
Health Canada (HC) has recently shifted towards psychedelic-assisted psychotherapies in safe, controlled environments as acceptable treatment options.
Pursuant to Section 56 exemption from the Canadian Drugs and Substances Act to treat anxiety associated diagnoses,MEDCAN BIOTECH will apply to Health Canada to receive approval under the Controlled Drug and Substances Act to allow MEDCAN BIOTECH to conduct research in order to effectively standardize the extraction of psilocybin from mushrooms.
The Health Canada permit by MEDCAN BIOTECH will allow it to develop and license intellectual property (IP) exclusively for further product development by PRIMO via chemo-typing and geno-typing of 5 different mushrooms to understand their properties.
MEDCAN BIOTECHwill proceed to patent methods of analysis and results on behalf of PRIMO, whereby data generated will be used in the production of nutraceutical products.
All IP and products developed as a result of the analysis will become the property of PRIMOfor their exclusive use.
Psychedelic research focused on psychedelic medicine and psychedelic drugs have demonstrated that these substances have potential for treating ailments including anxiety, addiction, depression, substance dependency, attention deficit hyperactivity disorder and even post-traumatic stress disorder.The data produced can be used to generate premium natural health mushroom nutraceutical products. Genotyping can be used for the identification and labeling of different varieties of psilocybin mushrooms.
EnWave Corporation (TSX-V:ENW) announced today that it has signed a Technology Evaluation and License Option Agreement with an American industrial hemp producer to evaluate the potential commercial use of the Company’s proprietary Radiant Energy Vacuum (“REV™”) dehydration technology. During the term of the TELOA, the Hemp Producer will pay a monthly evaluation fee and have the exclusive option to license REV™ technology for
use in the State of Illinois to dehydrate hemp products for cannabidiol (“CBD”) extraction.
If REV™ demonstrates its proven ability to produce dried hemp with zero degradation of CBD content, the Hemp Producer will be able to leverage EnWave’s patented dehydration platform to improve processing efficiencies and lower their cost of CBD production. If the evaluation is deemed successful by the Hemp Producer, EnWave will aim to sign a royalty-bearing commercial license agreement and an Equipment Purchase Agreement with the Hemp Producer committing to the purchase of REV™ machinery.
EnWave holds a robust intellectual property portfolio spanning numerous international markets and has licensed REV™ technology to more than forty companies operating in eighteen countries worldwide.
Isracann Biosciences Inc. (CSE: IPOT) (OTC: ISCNF), an Israel-based company focused on becoming a premier low cost, high quality cannabis producer, announced that the government of Israel has officially enacted the legislation for the export of medical cannabis, clearing the way for sales abroad that the government expects could generate more than 1 billion shekels ($273 million) in annual revenue.
Economy Minister Eli Cohen gave final approval for the exports more than a year after the cabinet initially supported the legislation. Within Israel, medical use of cannabis is permitted with recreational use largely decriminalised. The ministry reports about 70,000 Israelis currently use medical cannabis consuming an estimated 25 tonnes per year. If this growth trend continues, Israel could see a market of over 200,000 medical patients consuming 85 tonnes per year within the next two years.
As reported by Reuters, Hagit Weinstock, co-founder of the Weinstock-Zehavi & Co. law firm and a pioneer of cannabis regulation in Israel stated, “There are many investments that we are expected to see happening now, because investors were waiting for this approval.”
According to recent reports, the Israeli Ministry of Health has launched a new pilot program whereby medical cannabis producers will be approved to export medical cannabis, subject to concurrent product availability to Israeli patients at a fixed discount price of NIS14 per gram (CAD$5.50 per gram) for patients over 21 years old, and NIS10 (CAD$4.00 per gram) for those patients under 21 years old.
Previous reports have outlined how Israel has struggled with cannabis product shortages, as well as complaints about price and quality, which led to the country becoming one of the world’s largest importers of medical cannabis. The pilot program is planned for an initial three-month period during which the specific medical cannabis products to be provided in Israel and made available for export are at the individual producer’s discretion.
Company COO Matt Chatterton notes, “Todays news is a win-win for both the medical patients in Israel and the domestic producers. Export licensing will be a huge economic driver for the licensed producers and an incentive for investment that should spur rapid growth across the industry. The government’s plan to ensure subsidies for the domestic market will see supply finally catch up to demand along with stabilization of the supply chain through improved product processing and quality assurance that is required for entry into export markets. Its been an extensive process to get to where we are today, but with todays announcement we find ourselves in great shape as we continue to build our company and shareholder value in Israel.”
Fire & Flower Holdings Corp. (TSX: FAF) (OTCQX: FFLWF) and its wholly-owned subsidiary Fire & Flower Inc. today announced the launch of a private-label brand collaboration with Decibel Cannabis Company Inc's, premium cannabis brand "Qwest".
The brand collaboration is anticipated to launch on October 15, 2020 in the province of Saskatchewan. Decibel will manufacture, package and ship the private-label products to Open Fields Distribution, Fire & Flower's wholly-owned Saskatchewan distribution business.
The initial product launch will include a pre-rolled format and the Company may look to expand the offering to other products in the future. Spark Perks™ members will receive special member-only pricing and exclusive early access when the products are available in retail stores this week.
"We are pleased to announce this curated product offering to our customers. Qwest products are in high demand in the premium cannabis product category and our collaboration on these private label products will deliver high quality and value to the Fire & Flower customer," shared Nadia Vattovaz, Executive Vice President, Operations and Chief Financial Officer of Fire & Flower. "Our ability to work directly with licensed producers, though our wholesale business, Open Fields Distribution in the province of Saskatchewan demonstrates how this province is leading the Canadian cannabis industry and we believe other provinces should look to how this model can best serve consumers and help eradicate the illegal and unregulated market."
"Decibel is excited to partner with Canada's leading retailer to launch a series of premium pre-rolls, exclusively for Fire & Flower customers," said Adam Coates, Chief Growth Officer of Decibel. "This collaboration allows Qwest the opportunity to provide craft cannabis to a group of new customers while also offering value to Fire & Flower Spark Perks members."
Once again, today’s podcast is sponsored by Cannabis Suisse Corp. (OTC: CSUI ), a fully licensed cannabis cultivation and distribution company in Switzerland, for recreational tobacco products and medical CBD oils. The Company's products are laboratory tested to ensure the end users have access to a standardized, safe and consistent product. Cannabis Suisse Corp. currently sells via a distribution network of Swiss retailers and online shops, under the retail brand Alpine Cannabis.
Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and that this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment.
Learn more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
Investors can trade these stocks and other ideas on our site using our list of top stock trading apps including Robinhood, Acorn, Stash and others.
Learn more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
Investorideas.com podcasts are also available on iTunes, Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708
Follow us on Twitter https://twitter.com/Investorideas
Follow us on Facebook https://www.facebook.com/Investorideas
Follow us on YouTube https://www.youtube.com/c/Investorideas
Download our Mobile App for iPhone and Android
Join our Investor Club https://www.investorideas.com/membership/
800 665 0411